Jubilant Pharmova Dividends and Buybacks
Dividend criteria checks 3/6
Jubilant Pharmova is a dividend paying company with a current yield of 0.45%.
Key information
0.4%
Dividend yield
0.03%
Buyback Yield
| Total Shareholder Yield | 0.5% |
| Future Dividend Yield | 0.6% |
| Dividend Growth | -4.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹5.000 |
| Payout ratio | 103% |
Recent dividend and buyback updates
Recent updates
Jubilant Pharmova (NSE:JUBLPHARMA) Has A Somewhat Strained Balance Sheet
Nov 15
A Look At The Intrinsic Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)
Oct 27Jubilant Pharmova Limited (NSE:JUBLPHARMA) Surges 25% Yet Its Low P/S Is No Reason For Excitement
Aug 24Jubilant Pharmova (NSE:JUBLPHARMA) Has A Somewhat Strained Balance Sheet
Jul 13Jubilant Pharmova (NSE:JUBLPHARMA) Has A Somewhat Strained Balance Sheet
Mar 14Jubilant Pharmova Limited (NSE:JUBLPHARMA) Shares Fly 27% But Investors Aren't Buying For Growth
Dec 23These 4 Measures Indicate That Jubilant Pharmova (NSE:JUBLPHARMA) Is Using Debt Extensively
Dec 02These 4 Measures Indicate That Jubilant Pharmova (NSE:JUBLPHARMA) Is Using Debt Extensively
Jul 26Estimating The Fair Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)
May 11Is Jubilant Pharmova (NSE:JUBLPHARMA) A Risky Investment?
Dec 10Jubilant Pharmova (NSE:JUBLPHARMA) Has Announced A Dividend Of ₹5.00
Aug 01Does Jubilant Pharmova (NSE:JUBLPHARMA) Have A Healthy Balance Sheet?
Jun 15Calculating The Intrinsic Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)
Mar 22Is Jubilant Pharmova (NSE:JUBLPHARMA) A Risky Investment?
Feb 15Calculating The Intrinsic Value Of Jubilant Pharmova Limited (NSE:JUBLPHARMA)
Dec 20Here's Why It's Unlikely That Jubilant Pharmova Limited's (NSE:JUBLPHARMA) CEO Will See A Pay Rise This Year
Sep 15Here's Why Jubilant Pharmova (NSE:JUBLPHARMA) Can Manage Its Debt Responsibly
Aug 21Time To Worry? Analysts Are Downgrading Their Jubilant Pharmova Limited (NSE:JUBLPHARMA) Outlook
Jun 08An Intrinsic Calculation For Jubilant Pharmova Limited (NSE:JUBLPHARMA) Suggests It's 39% Undervalued
May 25Analysts Just Made A Major Revision To Their Jubilant Pharmova Limited (NSE:JUBILANT) Revenue Forecasts
Feb 10Estimating The Fair Value Of Jubilant Pharmova Limited (NSE:JUBILANT)
Feb 08
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: JUBLPHARMA's dividends per share have been stable in the past 10 years.
Growing Dividend: JUBLPHARMA's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Jubilant Pharmova Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (JUBLPHARMA) | 0.4% |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.2% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (JUBLPHARMA) (up to 3 years) | 0.6% |
Notable Dividend: JUBLPHARMA's dividend (0.45%) is higher than the bottom 25% of dividend payers in the Indian market (0.25%).
High Dividend: JUBLPHARMA's dividend (0.45%) is low compared to the top 25% of dividend payers in the Indian market (1.15%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (102.8%), JUBLPHARMA's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: JUBLPHARMA is paying a dividend but the company has no free cash flows.